Antiplatelets and anticoagulants in vitreoretinal surgery, with a special emphasis on novel anticoagulants: a national survey and review
Authors:
- 18 April 2017
- journal article
- review article
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 255 (7) , 1275-1285
Abstract
To survey current practice and opinion regarding the cessation of antiplatelet and anticoagulant agents prior to vitreoretinal surgery, with special emphasis on novel anticoagulants, and to provide an overview of current literature.Keywords
This publication has 28 references indexed in Scilit:
- Rivaroxaban and other novel oral anticoagulants: pharmacokinetics in healthy subjects, specific patient populations and relevance of coagulation monitoringThrombosis Journal, 2013
- Maintenance of perioperative antiplatelet and anticoagulant therapy for vitreoretinal surgeryClinical & Experimental Ophthalmology, 2012
- ANATOMICAL AND VISUAL RESULTS OF TRANSCONJUNCTIVAL SUTURELES VITRECTOMY USING SUBCONJUNCTIVAL ANESTHESIA PERFORMED ON SELECT PATIENTS TAKING ANTICOAGULANT AND ANTIPLATELET AGENTSRetina, 2012
- Antiplatelet and Anticoagulation Therapy in Vitreoretinal SurgeryAmerican Journal of Ophthalmology, 2011
- Comparison of Hemorrhagic Complications of Warfarin and Clopidogrel Bisulfate in 25-Gauge Vitrectomy versus a Control GroupOphthalmology, 2011
- Warfarin in vitreoretinal surgery: a case controlled seriesBritish Journal of Ophthalmology, 2010
- The current role of anticoagulants in cardiovascular medicineJournal of Cardiovascular Medicine, 2009
- Predictive clinical features and outcomes of vitrectomy for proliferative diabetic retinopathyBritish Journal of Ophthalmology, 2008
- Prasugrel versus Clopidogrel in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 2007
- ANTICOAGULATION WITH WARFARIN IN VITREORETINAL SURGERYRetina, 2007